These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8736674)

  • 1. Cross-cultural miscommunication.
    Kang-Yum E
    Hastings Cent Rep; 1996; 26(3):46. PubMed ID: 8736674
    [No Abstract]   [Full Text] [Related]  

  • 2. Postmarketing modifications in the safety labeling of the new antiepileptics.
    Buck ML; Gurka MJ; Goodkin HP
    Neurology; 2007 May; 68(18):1536-7. PubMed ID: 17470758
    [No Abstract]   [Full Text] [Related]  

  • 3. [To strengthen the monitoring and research on clinical adverse drug reaction induced by Chinese medicines].
    Chen K
    Zhonghua Yi Xue Za Zhi; 2001 Sep; 81(18):1091. PubMed ID: 11766603
    [No Abstract]   [Full Text] [Related]  

  • 4. Reporting adverse vaccine events.
    O'Rourke K
    J Am Vet Med Assoc; 2003 Sep; 223(6):753-4. PubMed ID: 14507079
    [No Abstract]   [Full Text] [Related]  

  • 5. Invited commentary--prescription drug label adverse events: a call for prioritization: comment on "A quantitative analysis of adverse events and 'overwarning' in drug labeling".
    Cheng C; Guglielmo BJ
    Arch Intern Med; 2011 May; 171(10):946-7. PubMed ID: 21606102
    [No Abstract]   [Full Text] [Related]  

  • 6. Lessons from cisapride.
    CMAJ; 2001 May; 164(9):1269, 1271. PubMed ID: 11341130
    [No Abstract]   [Full Text] [Related]  

  • 7. Cisapride and patient information leaflets.
    Sukkari SR; Sasich LD
    CMAJ; 2001 May; 164(9):1276-8; author reply 1278-9. PubMed ID: 11341134
    [No Abstract]   [Full Text] [Related]  

  • 8. Are national quality standards for traditional Chinese herbal medicine sufficient? Current governmental regulations for traditional Chinese herbal medicine in certain Western countries and China as the Eastern origin country.
    Dobos GJ; Tan L; Cohen MH; McIntyre M; Bauer R; Li X; Bensoussan A
    Complement Ther Med; 2005 Sep; 13(3):183-90. PubMed ID: 16150372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse drug reactions in elderly patients: alternative approaches to postmarket surveillance.
    Noah BA; Brushwood DB
    J Health Law; 2000; 33(3):383-454. PubMed ID: 11184355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. US pharmacy chain tracks customer's use of herbals.
    Helwig D
    CMAJ; 2000 Mar; 162(6):852. PubMed ID: 10750475
    [No Abstract]   [Full Text] [Related]  

  • 11. [All use of new drugs should be registered. It's the only way to get early warning on unexpected adverse effects].
    Werkö L
    Lakartidningen; 1999 Oct; 96(40):4284-6. PubMed ID: 10544592
    [No Abstract]   [Full Text] [Related]  

  • 12. Red sky in the morning: modifying prescription drug labels as a result of postmarket surveillance.
    Jacobson JD; Feigal D
    Food Drug Law J; 2007; 62(3):529-46. PubMed ID: 17915395
    [No Abstract]   [Full Text] [Related]  

  • 13. Suicidality following black-box warning.
    Wolf DV
    J Am Acad Child Adolesc Psychiatry; 2005 May; 44(5):405. PubMed ID: 15843759
    [No Abstract]   [Full Text] [Related]  

  • 14. Similar drug names cause concern.
    Carter AO
    Can Fam Physician; 1993 Apr; 39():754. PubMed ID: 8495131
    [No Abstract]   [Full Text] [Related]  

  • 15. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
    Wysowski DK; Swartz L
    Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug withdrawals from the Canadian market for safety reasons, 1963-2004.
    Lexchin J
    CMAJ; 2005 Mar; 172(6):765-7. PubMed ID: 15767610
    [No Abstract]   [Full Text] [Related]  

  • 17. [Suggestion on standardizing clinical standard of medicinal materials and cut crude drugs in Chinese Pharmacopoeia 2010 edition].
    Gao X; Zhang B; Zhong G; Zhang D
    Zhongguo Zhong Yao Za Zhi; 2009 Nov; 34(22):2972-4. PubMed ID: 20209969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analyze causes of adverse reactions induced by traditional Chinese medicine injections from its quality standards].
    Cui HY; Liang AH
    Zhongguo Zhong Yao Za Zhi; 2014 Mar; 39(5):934-40. PubMed ID: 25204194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Necessity of applying pharmacovigilance in post-marketing safety monitoring of traditional Chinese medicine injections].
    Wang HN; Chen W; Fu Z; Du WM; He J
    Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(5):612-4. PubMed ID: 18536393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-marketing surveillance and adverse drug reactions.
    Shani S
    Isr Med Assoc J; 1999 Oct; 1(2):117-9. PubMed ID: 10731310
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.